February 21, 2011

Sanofi Pasteur and International Vaccine Institute Partner against Dengue

 

Sanofi Pasteur and International Vaccine Institute Partner against Dengue

Lyon, France – February 21, 2011 – Sanofi Pasteur, the vaccines division of sanofi-aventis Group (EURONEXT: SAN and NYSE: SNY), announced today that it is partnering with the International Vaccine Institute (IVI) to support the recently launched Dengue Vaccine Initiative (DVI). Sanofi Pasteur and the IVI will aim to raise awareness and to work to move dengue vaccination higher on the global health agenda.